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Human Mesenchymal Stem Cells (hMSCs) are multipotent, immune-privileged, and possess the capacity to 
proliferate ex-vivo, making them a good candidate for stem cell therapy. However, a reliable scalable production 
system for hMSCs is needed to fuel the growing field of regenerative medicine. Current growth of hMSCs is 
achieved through adherent 2D methods using tissue culture flasks or cell factory systems. These processes are 
labor intensive and can lead to low purity and poor yield of hMSCs due to the limited control of culture conditions 
inherent in these systems. In this work, we are investigating a novel 3D honeycomb matrix culture system for 
controlled high density hMSC production. We have assessed compatibility of the hMSCs on the honeycomb 
matrix and developed a scale down model bioreactor for development and characterization. Computational Fluid 
Dynamic (CFD) modeling is used in parallel with the described in-vitro experimentation to characterize shear 
profiles and oxygen transport for optimization of the conditions to support high cell density hMSC cultures. 
These techniques will potentially allow for higher yield and purity of hMSCs to meet the large quantities of cells 
needed for emerging whole cell therapies. 
 
